Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:3809-3812. doi: 10.1109/EMBC46164.2021.9629704.
Radiomics was proposed to identify tumor phenotypes non-invasively from quantitative imaging features. Calculating a large amount of information on images, allows the development of reliable classification models. In multi-modal imaging protocols, the question arises of adding an imaging modality to improve model performance. In addition, in the implementation of clinical protocols, some modalities are not acquired or are of insufficient quality and cannot be reliably taken into account. Furthermore, multi-scanner studies generate some variability in the acquisition and data. Some methodological solutions using ComBat and a multi-model approach were tested to take these two issues into account. It was applied to a cohort of 88 patients with Diffuse Intrinsic Pontine Glioma (DIPG). Sixteen models using radiomic features computed using 0, 1, 2, 3 or 4 MRI modalities were proposed. Based on Leave-One-Out Cross-Validation, F1 weighted scores ranged from 0.66 to 0.85. A model of majority voting using the prediction of all the models available for one given patient was finally applied, reducing drastically the number of unclassified patients.Clinical relevance- In case of patients with DIPG, the prediction of H3 mutation is of prime importance in case of inconclusive biopsy or in the absence of it. It could suggest orientations for new chemotherapy drugs associated with the radiation therapy.
放射组学旨在从定量成像特征中无创地识别肿瘤表型。计算图像上的大量信息,允许开发可靠的分类模型。在多模态成像方案中,出现了添加一种成像方式以提高模型性能的问题。此外,在临床方案的实施中,一些方式无法获取或质量不足,无法可靠地考虑。此外,多扫描仪研究在采集和数据方面产生了一些可变性。一些使用 ComBat 和多模型方法的方法学解决方案已被测试以解决这两个问题。它应用于 88 名弥漫性内在脑桥胶质瘤 (DIPG) 患者的队列。使用从 0、1、2、3 或 4 种 MRI 方式计算的放射组学特征提出了 16 种模型。基于留一交叉验证,F1 加权评分范围为 0.66 至 0.85。最后应用了一种使用所有可用模型对给定患者的预测进行多数投票的模型,大大减少了未分类患者的数量。临床相关性-在 DIPG 患者的情况下,H3 突变的预测在活检不确定或不存在的情况下至关重要。它可以为与放射治疗相关的新化疗药物提供指导方向。